Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics. | Cancer Med | 2022 | 35037412 | PubTator, text mining | PubMed |
| RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea. | Blood Adv | 2022 | 35008096 | PubTator, text mining | PubMed |
| Global proteomics of fibroblast cells treated with bacterial cyclic dinucleotides, c-di-GMP and c-di-AMP. | J Oral Microbiol | 2022 | 34992733 | PubTator, text mining | PubMed |
| Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasets. | Hum Mol Genet | 2022 | 34957503 | PubTator, text mining | PubMed |
| Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors: A Review. | JAMA Oncol | 2022 | 34940799 | PubTator, text mining | PubMed |
| Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine-mapping in the MHC and genomewide. | HGG Adv | 2022 | 34927100 | PubTator, text mining | PubMed |
| HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases. | Transl Oncol | 2022 | 34922087 | PubTator, text mining | PubMed |
| Prediction of acute rejection in kidney transplanted patients based on the point-of-care isothermal molecular diagnostics platform. | Biosens Bioelectron | 2022 | 34920227 | PubTator, text mining | PubMed |
| Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells. | Inflamm Bowel Dis | 2022 | 34918082 | PubTator, text mining | PubMed |
| Nephrotoxicity evaluation of 3-monochloropropane-1,2-diol exposure in Sprague-Dawley rats using data-independent acquisition-based quantitative proteomics analysis. | Toxicol Lett | 2022 | 34915118 | PubTator, text mining | PubMed |
| Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies. | J Allergy Clin Immunol | 2022 | 34893352 | PubTator, text mining | PubMed |
| Evaluation of molecular apoptosis signaling pathways and its correlation with EBV viral load in SLE patients using systems biology approach. | Hum Antibodies | 2022 | 34864653 | PubTator, text mining | PubMed |
| The inhibitory effect of rBCG on EB virus-positive tumours using an EB virus fusion gene. | Appl Microbiol Biotechnol | 2022 | 34854938 | PubTator, text mining | PubMed |
| Development of isoquinolinone derivatives as immunoproteasome inhibitors. | Bioorg Med Chem Lett | 2022 | 34838650 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Systemic Autoinflammatory Diseases: A Growing Family of Disorders of Overlapping Immune Dysfunction. | Rheum Dis Clin North Am | 2022 | 34798958 | PubTator, text mining | PubMed |
| Analysis of independent cohorts of outbred CFW mice reveals novel loci for behavioral and physiological traits and identifies factors determining reproducibility. | G3 (Bethesda) | 2022 | 34791208 | PubTator, text mining | PubMed |
| Ethanol attenuates presentation of cytotoxic T-lymphocyte epitopes on hepatocytes of HBV-infected humanized mice. | Alcohol Clin Exp Res | 2022 | 34773268 | PubTator, text mining | PubMed |
| Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma. | Melanoma Res | 2022 | 34753889 | PubTator, text mining | PubMed |
| Enhancing 223Ra Treatment Efficacy by Anti-β1 Integrin Targeting. | J Nucl Med | 2022 | 34711616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=45